Treatment of symptomatic uterine fibroids with orally active gonadotropin-releasing hormone antagonists and add-back therapy

被引：0
|
作者：
Felberbaum, Ricardo [1 ]
Kupker, Wolfgang [2 ]
Diedrich, Klaus [3 ]
机构：
[1] Klinikverbund Allgau gGmbH, Klin Frauenheilkunde & Geburtshilfe, Klinikum Kempten & Klin Immenstadt, KinderWunschKempten KWK,Zent Gynakol Endokrinol &, Robert Weixler Str 50, D-87439 Kempten, Germany
[2] IVF Baden Baden, Zent Reprod Med & Gynakol Endokrinol, Baden Baden, Germany
[3] Univ Klinikum Schleswig Holstein, Klin Frauenheilkunde & Geburtshilfe, Campus Lubeck, Lubeck, Germany
来源：
GYNAKOLOGISCHE ENDOKRINOLOGIE | 2023年 / 21卷 / 02期
关键词：
LEIOMYOMAS;
D O I：
10.1007/s10304-023-00505-6
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：128 / 131
页数：4
相关论文
共 50 条
  • [41] Linzagolix with and without hormonal add-back therapy for the treatment of symptomatic uterine fibroids: two randomised, placebo-controlled, phase 3 trials
    Donnez, Jacques
    Taylor, Hugh S.
    Stewart, Elizabeth A.
    Bradley, Linda
    Marsh, Erica
    Archer, David
    Al-Hendy, Ayman
    Petraglia, Felice
    Watts, Nelson
    Gotteland, Jean-Pierre
    Bestel, Elke
    Terrill, Paul
    Loumaye, Ernest
    Humberstone, Andrew
    Garner, Elizabeth
    LANCET, 2022, 400 (10356): : 896 - 907
  • [42] The Impact of Preoperative Gonadotropin-Releasing Hormone Agonist Treatment on Women With Uterine Fibroids: A Meta-analysis
    Zhang, Ying
    Sun, Li
    Guo, Yinshu
    Cheng, Jiumei
    Wang, Yongjun
    Fan, Shuying
    Duan, Hua
    OBSTETRICAL & GYNECOLOGICAL SURVEY, 2014, 69 (02) : 100 - 108
  • [43] GONADOTROPIN-RELEASING HORMONE ANTAGONISTS AS TREATMENT FOR AUTOIMMUNE PROGESTERONE DERMATITIS
    Luu, J.
    Reddy, P.
    Kumar, M.
    Tsai, L.
    White, A.
    ANNALS OF ALLERGY ASTHMA & IMMUNOLOGY, 2024, 133 (06) : S207 - S207
  • [44] Progress towards the development of nonpeptide orally-active gonadotropin-releasing hormone (GnRH) antagonists: therapeutic implications
    Millar, RP
    Zhu, YF
    Chen, C
    Struthers, RS
    BRITISH MEDICAL BULLETIN, 2000, 56 (03) : 761 - 772
  • [45] Gonadotropin-Releasing Hormone Receptor Antagonist Mono- and Combination Therapy With Estradiol/Norethindrone Acetate Add-Back: Pharmacodynamics and Safety of OBE2109
    Pohl, Oliver
    Marchand, Line
    Fawkes, Neil
    Gotteland, Jean-Pierre
    Loumaye, Ernest
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2018, 103 (02): : 497 - 504
  • [46] STEROIDAL AND NONSTEROIDAL ADD-BACK THERAPY - EXTENDING SAFETY AND EFFICACY OF GONADOTROPIN-RELEASING-HORMONE AGONISTS IN THE GYNECOLOGIC PATIENT
    SURREY, ES
    FERTILITY AND STERILITY, 1995, 64 (04) : 673 - 685
  • [47] LONG-TERM GONADOTROPIN-RELEASING-HORMONE AGONIST THERAPY - THE EVOLVING ISSUE OF STEROIDAL ADD-BACK PARADIGMS
    ADASHI, EY
    HUMAN REPRODUCTION, 1994, 9 (07) : 1380 - 1397
  • [48] THE EFFECT OF HORMONAL ADD-BACK THERAPY IN ADOLESCENTS TREATED WITH A GONADOTROPIN RELEASING HORMONE (GNRH) AGONIST FOR ENDOMETRIOSIS: A RANDOMIZED TRIAL
    DiVasta, Amy D.
    Feldman, Henry A.
    Gallagher, Jenny Sadler
    Laufer, Marc R.
    Hornstein, Mark D.
    Gordon, Catherine M.
    JOURNAL OF ADOLESCENT HEALTH, 2015, 56 (02) : S24 - S24
  • [49] TREATMENT OF CRYPTORCHIDISM WITH PERNASAL GONADOTROPIN-RELEASING HORMONE THERAPY
    HAPP, J
    KOLLMANN, F
    KRAWEHL, C
    NEUBAUER, M
    KRAUSE, U
    DEMISCH, K
    SANDOW, J
    VONRECHENBERG, W
    BEYER, J
    FERTILITY AND STERILITY, 1978, 29 (05) : 546 - 551
  • [50] A randomized controlled trial of add-back estrogen or placebo on cognition in men with prostate cancer receiving an antiandrogen and a gonadotropin-releasing hormone analog
    Matousek, Rose H.
    Sherwin, Barbara B.
    PSYCHONEUROENDOCRINOLOGY, 2010, 35 (02) : 215 - 225
12345